Merck (MRK) Fiscal Q2 2026 Earnings Analysis: Key Metrics, Pipeline Shifts, and Short-Term Trading Setups
@nerdbull1669:
$Merck(MRK)$ is set to report its fiscal second-quarter 2026 financial results on Tuesday, August 4, 2026, before the market opens (with the investor call scheduled for 9:00 AM ET). Earnings Snapshot & Headline Estimates Consensus Revenue Estimate: ~$16.33 billion to $16.35 billion (representing ~2%–4% YoY growth). Consensus EPS Estimate: Loss of ($0.26) per share. Note on Earnings: The headline EPS reflects the impact of a ~$5.8 billion (~$2.35/share) upfront charge associated with Merck's acquisition of Terns Pharmaceuticals, which closed in May 2026. Full-Year 2026 Guidance: Prior FY26 adjusted EPS guidance was $5.04–$5.16. Investors will watch for updates reflecting recent M&A accounting adjustments. Merck & Co. (MRK) reported fisca